Artemis Medicare Services Limited

Web: artemishospitals.com NSE: ARTEMISMED BSE: 542919 SECTOR: Healthcare - Healthcare Services | Add Note | View Notes

332 12(4%)

Near 52W High of 339

Volume

2L as on 23, Jun

Open

317

High

327

Low

313

Close

320

VWAP

270

52 Week High

339

52 Week Low

203

Viand Research Rating
Quality Score

66/100

Growth Score

48/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy
Analyst Price Target
-
Market Cap (cr)

5,248

No. of Shares

15.8

P/E

70.24

P/B

10.1

Face Value

1

Div. Yield

-

Book Value (TTM)

-

CASH

-

DEBT

-

EPS (TTM)

-

ROE

14.37

ROCE

-

Profit Growth

-

Listing Date

23-Jan-20

Promoter Holding

58.39%

FII Holding

12.28%

DII Holding

2.4%

Price Chart
Price Performance
1 Week2%
1 Month2%
3 Months22%
6 Months16%
1 Year16%
YTD16%
Moving Average
5 Day SMA263
10 Day SMA262
20 Day SMA266
30 Day SMA269
50 Day SMA259
61 Day SMA252
80 Day SMA295
200 Day SMA0
PIVOT LEVEL
StandardCamarillaFibonacciWoodie's
Resistance 3295273286295
Resistance 2286272279286
Resistance 1277270275277
Pivot Point268268268268
Support 1259267261259
Support 2250265257250
Support 3241263250241
Competitors/Peers
#SymbolMCAPLTP1W1M6M1YP/EInd PEDebt/EqNP Qtr Rs.Cr.
1SUNPHARMA4,56,65518990%2%9%21%3757.70.0711509
2DIVISLAB2,43,19691612%8%44%51%6957.702568
3TORNTPHARM1,84,30348462%3%12%36%7257.71.792138
4APOLLOHOSP1,24,83486501%1%12%10%5857.70.92003
5ZYDUSLIFE1,12,89711324%2%26%13%2057.70.465124
6CIPLA1,11,34613852%5%3%12%2257.70.023862
7LAURUSLABS99,63418443%3%75%114%057.70.48890
8DRREDDY96,96211512%2%11%8%2057.70.24158
9MAXHEALTH96,6469851%10%8%14%057.70.321442
10LUPIN96,62021131%11%8%10%2357.70.295355
Load More
Shareholding Pattern (%)
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021
Promoters(0.01) 58.39%(0.01) 58.39%(-8.21) 58.38%(0.01) 66.53%(-0.61) 66.53%(0.01) 67.17%(0.01) 67.17%(-0.31) 67.17%(-0.51) 67.51%(0.01) 68.03%(0.01) 68.03%(0.01) 68.03%(-0.91) 68.03%(0.01) 68.91%(-0.41) 68.91%(-0.31) 69.27%(-0.21) 69.59%(0.01) 69.82%(0.01) 69.82%(0.01) 69.82%
FIIs(0.11) 12.28%(-0.31) 12.19%(12.11) 12.47%(0.11) 0.37%(-0.11) 0.24%(-0.31) 0.31%(0.41) 0.65%(0.11) 0.21%(0.11) 0.16%(0.01) 0.10%(0.01) 0.11%(0.01) 0.09%(0.11) 0.07%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%
DIIs(-0.51) 2.40%(0.01) 2.89%(-1.41) 2.91%(-0.51) 4.27%(-0.31) 4.76%(0.51) 5.04%(0.91) 4.51%(0.21) 3.60%(0.81) 3.45%(0.71) 2.61%(0.51) 1.96%(0.11) 1.51%(0.01) 1.41%(0.21) 1.37%(0.31) 1.15%(0.01) 0.90%(-0.21) 0.91%(-0.11) 1.10%(0.01) 1.22%(0.01) 1.22%
Government6.16%6.16%6.16%7.02%7.02%7.09%7.09%7.09%7.12%7.18%7.18%7.18%7.18%7.27%7.27%7.31%7.34%7.37%7.37%7.37%
Public20.76%20.37%20.07%21.81%21.45%20.39%20.59%21.93%21.76%22.08%22.72%23.18%23.30%22.43%22.65%22.53%22.17%21.71%21.59%21.59%
No. of Shareholders36,33532,04431,60233,55931,61428,39727,00426,05419,79519,99322,37520,52919,08218,10017,99514,63715,17712,09812,82710,765
Quarterly Results
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021
Sales287279272275255240232241223225219225210195187187167149144139122
Sales Growth % (YoY)12.7%16.4%17.2%13.8%14.2%6.5%6.2%7.3%6.5%15.3%16.7%20%25.3%30.7%30.1%34.8%36.8%15.7%16%50.6%95%
Sales Growth % (QoQ)2.9%2.6%-1.1%7.8%6.2%3.4%-3.7%8.1%-0.9%2.7%-2.7%7.1%7.7%4.3%-12%12.1%3.5%3.6%13.9%-
Expenses231228228224214204195199187187186191182170162164148132126119109
Operating Profit565245514136374236383334282626231917182013
OPM %201816181615161816171515131314131111121411
Other Income5848712974222121121111
Interest667778888988755544332
Depreciation131312121112111111111010998776655
Profit before tax4340303930292731222016191314131311810136
Tax %2625252429202328242929282624233122-61363641
Net Profit 3130223021232122171412141011109813684
Net Profit Growth % (QoQ)3.3%36.4%-26.7%42.9%-8.7%9.5%-4.5%29.4%21.4%16.7%-14.3%40%-9.1%10%11.1%12.5%-38.5%116.7%-25%100%-
Net Profit Growth % (YoY)47.6%30.4%4.8%36.4%23.5%64.3%75%57.1%70%27.3%20%55.6%25%-15.4%66.7%12.5%100%----
TTM Net Profit1131039695878374655750474540384036353118120
EPS in Rs1.981.91.412.161.531.671.51.621.221.040.8510.720.790.780.680.6310.490.620.29
Profit and Loss
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Sales1081937879737555408565547
Sales Growth %15.4%6.6%19.1%32.9%35.8%-27.7%3.4%-
Expenses893785746643487373503481
Operating Profit1881521339468356266
OPM %171615131291112
Other Income2733773742
Interest2832312012131311
Depreciation4845403122222320
Profit before tax13910868513783137
Tax %2524282516183645
Net Profit 1048249383161920
Net Profit Growth %26.8%67.3%28.9%22.6%416.7%-68.4%-5%-
EPS in Rs6.5563.622.882.40.491.490.97
Dividend Payout %7712160000
Cash Flows
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Cash from Operating Activity13215610912760275640
Cash from Investing Activity-90-393-88-158-107-37-26-50
Cash from Financing Activity-50264-29384418-2714
Net Cash Flow-827-87-3825
Balance Sheet
Mar 2026Sep 2025Mar 2025Sep 2024Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Equity Capital16141414141313131313
Reserves919869824779435390346307300280
Borrowings262279290320320286201147113114
Other Liabilities232264229226203216149133160147
Total Liabilities1429142613571339972905710600586554
Fixed Assets804794745735719605489383393381
CWIP29354044339564815649
Investments0000000000
Other Assets596597572561219205157136137124
Total Assets1429142613571339972905710600586554
Delivery

Delivery Data: ARTEMISMED

#Date
258
32%
339
Value (Cr)Q/T
42
Del
53
Del
11
14-Sep333
30
384012
23-Sep320
3
20532
32-Sep321
7
23544
41-Sep328
18
28407
531-Aug317
4
21602
628-Aug319
4
21532
727-Aug317
7
25524
826-Aug324
5
25482
925-Aug324
6
26503
1024-Aug329
15
29507
1121-Aug326
32
414414
1220-Aug321
22
484410
1319-Aug314
6
35543
1418-Aug312
7
43544
1517-Aug314
7
35624
1614-Aug315
5
28543
1713-Aug318
28
263410
1812-Aug316
22
485011
1911-Aug313
5
25483
2010-Aug316
15
29315
217-Aug316
9
45545
226-Aug312
14
34548
235-Aug322
42
544017
244-Aug302
22
705111
253-Aug302
8
49585
2631-Jul298
9
40616
2730-Jul302
18
46448
2829-Jul299
67
653222
2928-Jul277
3
32662
3027-Jul278
4
41602
3124-Jul276
3
27562
3223-Jul272
3
21682
3322-Jul273
4
34592
3421-Jul277
4
13673
3520-Jul271
4
28502
3617-Jul269
3
34511
3716-Jul275
3
36541
3815-Jul276
4
35643
3914-Jul271
6
23564
4013-Jul277
5
38613
4110-Jul277
9
44676
429-Jul268
5
21764
438-Jul264
5
44684
447-Jul273
4
46492
456-Jul276
21
69388
463-Jul260
2
30712
472-Jul260
3
33582
481-Jul263
2
31601
4930-Jun265
2
32501
5029-Jun263
2
35571
Daily Market Cap
DateTotal Market CapChangeChg %
04-Sep5,248c199c3.95
03-Sep5,048c190c3.63
01-Sep5,238c203c4.02
31-Aug5,036c36c0.71
27-Aug5,000c168c3.25
26-Aug5,168c29c0.55
25-Aug5,139c68c1.31
24-Aug5,207c24c0.45
21-Aug5,231c253c5.09
19-Aug4,978c55c1.13
18-Aug4,922c59c1.18
17-Aug4,981c8c0.16
14-Aug4,973c49c0.98
13-Aug5,022c67c1.31
12-Aug5,089c82c1.63
11-Aug5,007c00
10-Aug5,007c74c1.49
06-Aug4,933c161c3.38
04-Aug4,772c40c0.84
31-Jul4,732c48c0.99
30-Jul4,780c45c0.95
29-Jul4,735c345c7.86
28-Jul4,390c15c0.34
27-Jul4,405c46c1.05
24-Jul4,359c00
Stock Checklist
Price is above from 52 week high low average: 95%
Stock is trading above all short term SMAs: NO
Stock is trading above all long term SMAs: YES
Stock is Consistently Improving Long Term: NO
FII purchased in last quarter: YES
Promoters are buying the stock: NO
Mutual Fund Holdings

Held by 12 fund scheme(s) across 4 fund house(s) as of Aug26 · Total value ₹113 Cr · 4 increasing / 2 decreasing · View in MF Pro →

Fund HouseSchemesWeight %ChangeValue (Cr)
HSBC Mutual Fund22.10%+0.28%74.6
Bandhan Mutual Fund40.06%-32.3
LIC Mutual Fund42.45%+0.16%5.6
Motilal Oswal Mutual Fund20.00%-0
Strategy Builder
Bulk Deals
Events
News
Exchange Filings
Annual Reports
Ratings & Research Reports
Concalls
Announcements
0